New DM study points to muscle spindle pathology in dogs
Bottom line
A new paper in Animals examines pathology in the tibialis cranialis muscle of dogs with degenerative myelopathy, looking beyond the spinal cord to both extrafusal muscle fibers and intrafusal fibers within muscle spindles. The study adds to a growing body of work suggesting canine degenerative myelopathy is not only a central white matter disease, but a multisystem disorder with meaningful peripheral and proprioceptive involvement, which is especially relevant because the condition is widely used as a naturally occurring model for SOD1-associated amyotrophic lateral sclerosis. Prior work has already linked canine degenerative myelopathy to SOD1 mutations, peripheral neuropathy, muscle atrophy, and sensory pathway changes, and this new muscle-focused pathology study appears to extend that picture into the muscle spindle apparatus itself. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, the paper may help explain why dogs with degenerative myelopathy can show worsening proprioceptive deficits, gait instability, and muscle wasting that aren’t fully captured by thinking about the disease as spinal cord degeneration alone. That matters for case discussions, differential diagnosis workups, expectations around progression, and rehabilitation planning. In current practice, most neurologists and rehabilitation professionals already rely on history, neurologic findings, SOD1 testing, and often MRI for presumptive diagnosis, while using exercise and physical rehabilitation to preserve strength, coordination, and muscle mass. Findings that implicate muscle spindles and intramuscular pathology could sharpen how clinicians think about functional decline, even if they don’t immediately change standard management. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for follow-up studies tying these histopathology findings to clinical staging, biomarkers, imaging, or rehabilitation outcomes in living dogs. (jns-journal.com)
Key facts
- Study
- A new paper in Animals examines tibialis cranialis extrafusal and intrafusal myofibers in canine degenerative myelopathy.
- Disease
- Canine degenerative myelopathy is a progressive, adult-onset neurodegenerative disease.
- Model relevance
- The disease is used as a naturally occurring model for SOD1-associated amyotrophic lateral sclerosis.
- Pathology focus
- The study looks beyond the spinal cord to skeletal muscle fibers and muscle spindle fibers.
- Prior associations
- Earlier work linked canine degenerative myelopathy to SOD1 mutations, peripheral neuropathy, muscle atrophy, and sensory pathway changes.
- Clinical relevance
- The paper may help explain worsening proprioceptive deficits, gait instability, and muscle wasting in affected dogs.
- Current management
- Clinicians commonly use history, neurologic findings, SOD1 testing, and often MRI for presumptive diagnosis.
- Rehabilitation
- Exercise and physical rehabilitation are used to preserve strength, coordination, and muscle mass.
A newly published Animals study on tibialis cranialis extrafusal and intrafusal myofibers in canine degenerative myelopathy pushes the field a step further into peripheral tissue pathology, asking whether the disease’s effects extend into muscle spindles as well as skeletal muscle proper. That’s a notable shift in emphasis for a condition long framed primarily as a progressive spinal cord disease, even though clinicians have recognized for years that affected dogs also develop muscle atrophy, paresis, and sensory deficits. (mdpi.com)
Degenerative myelopathy is an adult-onset, progressive neurodegenerative disease of dogs, classically affecting older, large-breed patients and strongly associated with SOD1 mutations. It has become an important naturally occurring comparative model for some forms of human ALS. Earlier work established that the disease is not confined to the spinal cord: investigators have reported peripheral nerve pathology, denervation-type muscle atrophy in chronic cases, and evidence that sensory systems may contribute to disease progression. More recently, a 2026 Journal of the Neurological Sciences paper from Brandie R. Morgan-Jack and colleagues focused specifically on the pathology of general proprioception in this canine ALS model, reinforcing the relevance of sensory pathway dysfunction. (pubmed.ncbi.nlm.nih.gov)
That background makes the new tibialis cranialis paper particularly interesting. The tibialis cranialis is a logical target because pelvic limb dysfunction is one of the earliest and most clinically visible features of degenerative myelopathy, and prior muscle-focused work in DM has also used craniotibialis/tibialis cranialis muscle to track disease-related changes. Existing literature has already shown that electrical impedance myography can detect muscle pathology in dogs with DM, and diffusion tensor imaging studies have demonstrated spinal cord microstructural changes that correlate with neurologic severity. Taken together, the field has been building toward a more integrated view of disease burden across spinal cord, peripheral nerve, and muscle. (pubmed.ncbi.nlm.nih.gov)
The added wrinkle here is the emphasis on intrafusal fibers and muscle spindles. Muscle spindles are central to proprioception and reflex regulation, so pathology in that compartment could help connect histologic findings with the asymmetric proprioceptive ataxia and progressive paresis seen clinically in DM. More broadly, muscle spindle dysfunction has been implicated in unstable gait and ataxic behavior across neuromuscular diseases, and older pathology literature has shown that intrafusal fiber atrophy and degeneration can occur in denervation and other neuromuscular disorders. Based on the title and surrounding literature, the new study appears to support the idea that proprioceptive apparatus pathology is part of the canine DM phenotype, not just a secondary footnote. That last point is an inference from the study title and related publications, rather than a direct quote from the paper text. (link.springer.com)
Direct outside commentary on this specific paper was limited in open web results, but there is broader expert consensus on how DM is managed and monitored in practice. A 2023 survey of neurologists and rehabilitation professionals found that most clinicians use SOD1 testing, clinical history, and neurologic findings for presumptive diagnosis, with many also requiring MRI, and that exercise and physical rehabilitation are routinely recommended. Rehabilitation professionals reported goals that include preserving strength, coordination, muscle mass, and overall wellbeing. In that context, a study documenting more detailed muscle and spindle pathology may resonate most with neurologists, rehab clinicians, and comparative neuromuscular researchers, even before it changes bedside protocols. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary teams, this paper supports a more complete explanation of why dogs with degenerative myelopathy lose function the way they do. If proprioceptive structures inside muscle are affected alongside extrafusal fibers, it strengthens the case that declining gait, postural reactions, and muscle condition reflect a whole motor-sensory unit under strain, not simply an isolated upper motor neuron problem. That has practical value in counseling pet parents, setting realistic rehab goals, and interpreting why some dogs continue to decline despite supportive care. It also matters for comparative medicine: canine DM remains one of the best naturally occurring models for SOD1-associated ALS, and better characterization of peripheral and sensory pathology may improve translational relevance. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next step is whether these histopathology findings can be linked to antemortem tools and clinical decision-making. Biomarkers, advanced imaging, electrophysiology, and muscle-focused measures such as electrical impedance myography are all possible bridges between pathology and practice. Just as important, researchers will likely look for correlations between spindle or myofiber pathology and disease stage, breed, SOD1 genotype, or rehabilitation response. If those links emerge, this line of work could move from descriptive pathology into clinically actionable stratification. (pubmed.ncbi.nlm.nih.gov)